---
trial_id: 727
discovery_date: 2022-04-24 16:23:21.878254
date: 2022-04-24 16:23:21.878254
title: "A Two Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Teriflunomide Administered Orally Onc..."
summary: |
  <p>EudraCT Number: 2011-005249-12<br />Sponsor Protocol Number: EFC11759<br />Sponsor Name: Genzyme Corporation<br />Start Date: 2014-08-13<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Version: 17.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br /><br />Population Age: Children, Adolescents, Under 18<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/EE">EE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/BE">BE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/GR">GR</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/GB">GB</a> (GB - no longer in EU/EEA), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/FR">FR</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/LT">LT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/3rd">Outside EU/EEA</a>, <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/IE">IE</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/NL">NL</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/BG">BG</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/PT">PT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/SI">SI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/IT">IT</a> (Not Authorised)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005249-12'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2011-005249-12<br />Sponsor Protocol Number: EFC11759<br />Sponsor Name: Genzyme Corporation<br />Start Date: 2014-08-13<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Version: 17.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br /><br />Population Age: Children, Adolescents, Under 18<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/EE">EE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/BE">BE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/GR">GR</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/GB">GB</a> (GB - no longer in EU/EEA), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/FR">FR</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/LT">LT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/3rd">Outside EU/EEA</a>, <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/IE">IE</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/NL">NL</a> (Restarted), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/BG">BG</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/PT">PT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/SI">SI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005249-12/IT">IT</a> (Not Authorised)</p>